| |
| |
|
| Insider
Information: |
Barabe Timothy C |
| Relationship: |
Director |
| City: |
Woburn |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
663,514 |
|
|
Indirect Shares
|
7,120 |
|
|
| Direct
Value |
$1,621,107 |
|
|
|
Indirect Value
|
$142,400 |
|
|
| Total
Shares |
670,634 |
|
|
| Total
Value |
$1,763,507 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
5
|
5
|
|
Stock
price went up :
|
3
|
5
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.5
|
5.0
|
| Percentage
Gain/Loss : |
 51.6%
|
100.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Arqule Inc |
ARQL |
Director |
2020-01-16 |
0 |
2005-03-04 |
7,120 |
Premium* |
|
|
Human Genome Sciences Inc |
HGSI |
Chief Financial Officer |
2010-02-22 |
49,570 |
2007-06-27 |
0 |
Premium* |
|
|
Affymetrix Inc |
AFFX |
Chief Financial Officer |
2013-03-18 |
166,378 |
|
0 |
Premium* |
|
|
Acer Therapeutics Inc |
ACER |
Director |
2016-11-18 |
12,910 |
2014-03-19 |
0 |
Premium* |
|
|
Veeva Systems Inc |
VEEV |
Director |
2021-06-22 |
6,643 |
2015-12-09 |
0 |
Premium* |
|
|
Selecta Biosciences Inc |
SELB |
Director |
2024-01-02 |
428,013 |
2017-03-27 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
252 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 8 of 11
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARQL |
Arqule Inc |
Director |
– • – |
2009-05-18 |
4 |
B |
$4.11 |
$4,122 |
D/D |
1,003 |
25,136 |
2.31 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Chief Financial Officer |
• – – |
2009-06-30 |
4 |
B |
$1.80 |
$1,800 |
D/D |
1,000 |
45,274 |
2.66 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2009-07-24 |
4 |
B |
$5.82 |
$1,199 |
D/D |
206 |
25,342 |
2.31 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2009-08-05 |
4 |
B |
$5.73 |
$596 |
D/D |
104 |
25,446 |
2.31 |
- |
|
| ARQL |
Arqule Inc |
Director |
– • – |
2009-08-18 |
4 |
B |
$5.26 |
$4,124 |
D/D |
784 |
26,230 |
2.31 |
- |
|
| AFFX |
Affymetrix Inc |
Chief Financial Officer |
• – – |
2010-04-27 |
4 |
B |
$6.45 |
$32,250 |
D/D |
5,000 |
40,000 |
2.74 |
- |
|
| AFFX |
Affymetrix Inc |
Chief Financial Officer |
• – – |
2010-05-07 |
4 |
B |
$6.00 |
$30,820 |
D/D |
5,000 |
45,000 |
2.74 |
- |
|
| AFFX |
Affymetrix Inc |
Chief Financial Officer |
• – – |
2010-07-27 |
4 |
B |
$4.50 |
$45,000 |
D/D |
10,000 |
55,000 |
2.74 |
- |
|
| AFFX |
Affymetrix Inc |
Chief Financial Officer |
• – – |
2010-08-20 |
4 |
B |
$4.09 |
$40,900 |
D/D |
10,000 |
80,000 |
2.74 |
- |
|
| AFFX |
Affymetrix Inc |
Chief Financial Officer |
• – – |
2010-11-19 |
4 |
B |
$4.29 |
$21,443 |
D/D |
5,000 |
85,000 |
2.74 |
- |
|
| AFFX |
Affymetrix Inc |
Chief Financial Officer |
• – – |
2011-08-04 |
4 |
B |
$4.75 |
$47,500 |
D/D |
10,000 |
103,150 |
2.74 |
- |
|
| AFFX |
Affymetrix Inc |
Chief Financial Officer |
• – – |
2011-08-09 |
4 |
B |
$4.25 |
$42,500 |
D/D |
10,000 |
113,150 |
2.74 |
- |
|
| AFFX |
Affymetrix Inc |
Chief Financial Officer |
• – – |
2012-08-13 |
4 |
B |
$3.99 |
$17,756 |
D/D |
4,450 |
158,110 |
2.74 |
- |
|
| AFFX |
Affymetrix Inc |
Chief Financial Officer |
• – – |
2012-08-17 |
4 |
B |
$3.99 |
$22,145 |
D/D |
5,550 |
163,660 |
2.74 |
- |
|
| AFFX |
Affymetrix Inc |
Chief Financial Officer |
• – – |
2012-08-21 |
4 |
B |
$3.75 |
$37,500 |
D/D |
10,000 |
172,284 |
2.74 |
- |
|
| ACER |
Acer Therapeutics Inc |
Director |
– • – |
2014-09-17 |
4 |
B |
$1.15 |
$11,500 |
D/D |
10,000 |
16,000 |
2.39 |
- |
|
| SELB |
Selecta Biosciences Inc |
Director |
– • – |
2017-11-09 |
4 |
B |
$9.73 |
$24,335 |
D/D |
2,500 |
4,992 |
2.39 |
- |
|
| SELB |
Selecta Biosciences Inc |
Director |
– • – |
2017-11-10 |
4 |
B |
$9.00 |
$22,505 |
D/D |
2,500 |
7,492 |
2.39 |
- |
|
| SELB |
Selecta Biosciences Inc |
Director |
– • – |
2019-08-13 |
4 |
B |
$1.72 |
$17,200 |
D/D |
10,000 |
17,492 |
2.39 |
- |
|
| SELB |
Selecta Biosciences Inc |
Director |
– • – |
2020-03-17 |
4 |
B |
$2.00 |
$10,000 |
D/D |
5,000 |
88,173 |
2.39 |
% |
|
| SELB |
Selecta Biosciences Inc |
Director |
– • – |
2020-10-06 |
4 |
B |
$1.68 |
$83,985 |
D/D |
50,000 |
171,013 |
2.39 |
% |
|
| SELB |
Selecta Biosciences Inc |
Director |
– • – |
2021-03-26 |
4 |
B |
$4.10 |
$41,000 |
D/D |
10,000 |
181,013 |
2.39 |
% |
|
| SELB |
Selecta Biosciences Inc |
Director |
– • – |
2021-08-18 |
4 |
B |
$4.00 |
$36,000 |
D/D |
9,000 |
190,013 |
2.39 |
% |
|
| SELB |
Selecta Biosciences Inc |
Director |
– • – |
2022-05-09 |
4 |
B |
$0.77 |
$38,720 |
D/D |
50,000 |
250,013 |
2.39 |
% |
|
| AFFX |
Affymetrix Inc |
Chief Financial Officer |
• – – |
2011-03-18 |
4 |
D |
$4.60 |
$8,510 |
D/D |
(1,850) |
93,150 |
0 |
- |
|
252 Records found
|
|
Page 8 of 11 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
